CLBT — Cellebrite DI Income Statement

0.000.00%

Last trade - 00:00

TechnologyBalancedLarge CapHigh Flyer

Annual income statement for Cellebrite DI, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	20-F	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	195	246	271	325	401
Cost of Revenue
Gross Profit	157	204	220	272	339
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	186	232	270	292	344
Operating Profit	9.22	13.8	1.04	33.2	56.9
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	11.4	82.3	121	-75.6	-276
Provision for Income Taxes
Net Income After Taxes	5.78	71.4	121	-81.1	-283
Net Income Before Extraordinary Items
Net Income	5.78	71.4	121	-81.1	-283
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-9.34	70.4	116	-81.1	-283
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.05	0.428	0.616	-0.426	-1.35
Dividends per Share